```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 524 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 524

   To authorize the Attorney General to award grants to address the 
    national epidemics of prescription opioid abuse and heroin use.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 12, 2015

 Mr. Whitehouse (for himself, Mr. Portman, Ms. Klobuchar, Ms. Ayotte, 
Mr. Coons, and Mr. Kirk) introduced the following bill; which was read 
          twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
   To authorize the Attorney General to award grants to address the 
    national epidemics of prescription opioid abuse and heroin use.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Comprehensive 
Addiction and Recovery Act of 2015''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Findings.
Sec. 3. Definitions.
                   TITLE I--PREVENTION AND EDUCATION

Sec. 101. Development of best prescribing practices.
Sec. 102. National education campaign.
Sec. 103. Community-based coalition enhancement grants to address local 
                            drug crises.
                TITLE II--LAW ENFORCEMENT AND TREATMENT

Sec. 201. Treatment alternative to incarceration programs.
Sec. 202. Law enforcement naloxone training and implementation 
                            demonstration.
Sec. 203. Prescription drug take back expansion.
                   TITLE III--TREATMENT AND RECOVERY

Sec. 301. Evidence-based opioid and heroin treatment and interventions 
                            demonstration.
Sec. 302. Criminal justice medication assisted treatment and 
                            interventions demonstration.
Sec. 303. National youth recovery initiative.
Sec. 304. Building communities of recovery.
              TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

Sec. 401. Correctional education demonstration grant program.
Sec. 402. Revision of FAFSA form.
Sec. 403. National Task Force on Recovery and Collateral Consequences.
  TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND 
                                VETERANS

Sec. 501. Authority to award competitive grants to address opioid and 
                            heroin abuse by pregnant and parenting 
                            female offenders.
Sec. 502. Grants for family-based substance abuse treatment.
Sec. 503. Veterans' treatment courts.
  TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS 
                        OPIOID AND HEROIN ABUSE

Sec. 601. State demonstration grants for comprehensive opioid abuse 
                            response.
                     TITLE VII--OFFSET; GAO REPORT

Sec. 701. Offset.
Sec. 702. GAO report on IMD exclusion.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) The abuse of heroin and prescription painkillers is 
        having a devastating effect on public health and safety in 
        communities across the United States. According to the Centers 
        for Disease Control and Prevention, drug overdose deaths now 
        surpass traffic crashes in the number of deaths caused by 
        injury in the United States. In 2011, an average of about 110 
        people in the United States died from drug overdose every day.
            (2) Law enforcement officials and treatment experts 
        throughout the country report that many prescription opioid 
        users have turned to heroin as a cheaper or more easily 
        obtained alternative to prescription drugs.
            (3) Opioid pain relievers are the most widely misused or 
        abused controlled prescription drugs (commonly referred to as 
        ``CPDs'') and are involved in most CPD-related overdose 
        incidents. According to the Drug Abuse Warning Network 
        (commonly known as ``DAWN''), the estimated number of emergency 
        department visits involving nonmedical use of prescription 
        opiates or opioids increased by 112 percent between 2006 and 
        2010, from 84,671 to 179,787.
            (4) According to a report by the National Association of 
        State Alcohol and Drug Abuse Directors (commonly referred to as 
        ``NASADAD''), 37 States reported an increase in admissions to 
        treatment for heroin use during the past 2 years, while 
        admissions to treatment for prescription opiates increased 500 
        percent from 2000 to 2012.
            (5) Substance use disorders are a treatable disease. 
        Discoveries in the science of addiction have led to advances in 
        the treatment of substance use disorders that help people stop 
        abusing drugs and prescription medications and resume their 
        productive lives.
            (6) According to the National Survey on Drug Use and 
        Health, approximately 22,700,000 people in the United States 
        needed substance use disorder treatment in 2013, but only 
        2,500,000 people received it. Furthermore, current treatment 
        services are not adequate to meet demand. According to a report 
        commissioned by SAMHSA, there are approximately 32 providers 
        for every 1,000 individuals needing substance use disorder 
        treatment. In some States, the ratio is much lower.
            (7) Effective substance abuse prevention can yield major 
        economic dividends.
            (8) According to the National Institute on Drug Abuse, when 
        schools and communities properly implement science-validated 
        substance abuse prevention programs, abuse of alcohol, tobacco, 
        and illicit drugs is reduced. Such programs help teachers, 
        parents, and healthcare professionals shape the perceptions of 
        youths about the risks of drug abuse.
            (9) Diverting individuals with substance use disorders from 
        criminal justice systems into community-based treatment can 
        save billions of dollars and prevent sizeable numbers of 
        crimes, arrests, and re-incarcerations over the course of those 
        individuals' lives.
            (10) According to the Drug Enforcement Agency, more than 
        1,700 tons of expired, unwanted prescription medications have 
        been collected during the past 3\1/2\ years, following the 
        enactment of the Secure and Responsible Drug Disposal Act of 
        2010 (Public Law 111-273; 124 Stat. 2858).
            (11) Research shows that combining treatment medications 
        with behavioral therapy is the best way to facilitate success 
        for most patients. Treatment approaches must be tailored to 
        address the drug abuse patterns and drug-related medical, 
        psychiatric, and social problems of each individual. Different 
        types of medications may be useful at different stages of 
        treatment or recovery to help a patient stop using drugs, stay 
        in treatment, and avoid relapse.
            (12) Research indicates that combating the opioid crisis, 
        including abuse of prescription painkillers and, increasingly, 
        heroin, requires a multi-pronged approach that involves 
        reducing drug diversion, expanding delivery of existing 
        treatments (including medication assisted treatments), 
        expanding access to overdose medications and interventions, and 
        the development of new medications for pain that can augment 
        the existing treatment arsenal.
            (13) Individuals with mental illness, especially severe 
        mental illness, are at considerably higher risk for substance 
        abuse than the general population, and the presence of a mental 
        illness complicates recovery from substance abuse.

SEC. 3. DEFINITIONS.

    In this Act--
            (1) the term ``medication assisted treatment'' means the 
        use, for problems relating to heroin and other opioids, of 
        medications approved by the Food and Drug Administration in 
        combination with counseling and behavioral therapies;
            (2) the term ``ONDCP Recovery Branch'' means the Recovery 
        Branch of the Office of National Drug Control Policy;
            (3) the term ``opioid'' means any drug having an addiction-
        forming or addiction-sustaining liability similar to morphine 
        or being capable of conversion into a drug having such 
        addiction-forming or addiction-sustaining liability; and
            (4) the term ``State'' means any State of the United 
        States, the District of Columbia, the Commonwealth of Puerto 
        Rico, and any territory or possession of the United States.

                   TITLE I--PREVENTION AND EDUCATION

SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.

    (a) Inter-Agency Task Force.--Not later than 120 days after the 
date of enactment of this Act, the Secretary of Health and Human 
Services (referred to in this section as the ``Secretary''), in 
cooperation with the Secretary of Veterans Affairs, the Secretary of 
Defense, and the Administrator of the Drug Enforcement Administration, 
shall convene a Pain Management Best Practices Inter-Agency Task Force 
(referred to in this section as the ``task force'').
    (b) Membership.--The task force shall be comprised of--
            (1) representatives of--
                    (A) the Department of Health and Human Services;
                    (B) the Department of Veterans Affairs;
                    (C) the Department of Defense;
                    (D) the Drug Enforcement Administration;
                    (E) the Centers for Disease Control and Prevention;
                    (F) the Institute of Medicine; and
                    (G) the Office of National Drug Control Policy;
            (2) the Director of the National Institutes of Health;
            (3) physicians, dentists, and non-physician prescribers;
            (4) pharmacists;
            (5) experts in the fields of pain research and addiction 
        research;
            (6) representatives of--
                    (A) pain management professional organizations;
                    (B) the mental health treatment community;
                    (C) the addiction treatment community;
                    (D) pain advocacy groups; and
                    (E) groups with expertise around overdose reversal; 
                and
            (7) other stakeholders, as the Secretary determines 
        appropriate.
    (c) Duties.--The task force shall--
            (1) not later than 180 days after the date on which the 
        task force is convened under subsection (a), develop best 
        practices for pain management (including chronic and acute 
        pain) and prescribing pain medication, taking into 
        consideration--
                    (A) existing pain management research;
                    (B) recommendations from relevant conferences;
                    (C) ongoing efforts at the State and local levels 
                and by medical professional organizations to develop 
                improved pain management strategies; and
                    (D) the management of high-risk populations, other 
                than populations who suffer pain, who--
                            (i) may use or be prescribed 
                        benzodiazepines, alcohol, and diverted opioids; 
                        or
                            (ii) receive opioids in the course of 
                        medical care;
            (2) solicit and take into consideration public comment on 
        the practices developed under paragraph (1), amending such best 
        practices if appropriate; and
            (3) develop a strategy for disseminating information about 
        the best practices developed under paragraphs (1) and (2) to 
        prescribers, health professionals, pharmacists, State medical 
        boards, and other parties, as the Secretary determines 
        appropriate.
    (d) Limitation.--The task force shall not have rulemaking 
authority.
    (e) Report.--Not later than 270 days after the date on which the 
task force is convened under subsection (a), the task force shall 
submit to Congress a report that includes--
            (1) the strategy for disseminating best practices developed 
        under subsection (c);
            (2) the results of a feasibility study on linking best 
        practices developed under subsection (c) to receiving and 
        renewing registrations under section 303(f) of the Controlled 
        Substances Act (21 U.S.C. 823(f)); and
            (3) recommendations on how to apply best practices 
        developed under subsection (c) to improve prescribing practices 
        at medical facilities, including medical facilities of the 
        Veterans Health Administration.

SEC. 102. NATIONAL EDUCATION CAMPAIGN.

    Title I of the Omnibus Crime Control and Safe Streets Act of 1968 
(42 U.S.C. 3711 et seq.) is amended by adding at the end the following:

                    ``PART MM--DRUG TREATMENT GRANTS

``SEC. 3031. DEFINITIONS.

    ``In this part--
            ``(1) the term `civil liability protection law' means a 
        State law that protects from civil liability individuals who 
        give aid on a voluntary basis in an emergency to individuals 
        who are ill, in peril, or otherwise incapacitated;
            ``(2) the term `medication assisted treatment' means the 
        use, for problems relating to heroin and other opioids, of 
        medications approved by the Food and Drug Administration in 
        combination with counseling and behavioral therapies;
            ``(3) the term `opioid' means any drug having an addiction-
        forming or addiction-sustaining liability similar to morphine 
        or being capable of conversion into a drug having such 
        addiction-forming or addiction-sustaining liability; and
            ``(4) the term `Single State Authority for Substance Abuse' 
        has the meaning given the term in section 201(e) of the Second 
        Chance Act of 2007 (42 U.S.C. 17521(e)).

``SEC. 3032. NATIONAL EDUCATION CAMPAIGN.

    ``(a) Definitions.--In this section--
            ``(1) the term `eligible entity' means a State, unit of 
        local government, or nonprofit organization; and
            ``(2) the terms `elementary school' and `secondary school' 
        have the meaning given those terms in section 9101 of the 
        Elementary and Secondary Education Act of 1965 (20 U.S.C. 
        7801).
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Secretary of Health and Human Services, the Director of the 
Office of National Drug Control Policy, the Secretary of Education, the 
Administrator of the Substance Abuse and Mental Health Services 
Administration, and the Director of the Centers for Disease Control and 
Prevention, may make grants to eligible entities to expand educational 
efforts to prevent abuse of opioids, heroin, and other substances of 
abuse, understand addiction as a chronic disease, and promote treatment 
and recovery, including--
            ``(1) parent and caretaker-focused prevention efforts, 
        including--
                    ``(A) the development of research-based community 
                education online and social media materials with an 
                accompanying toolkit that can be disseminated to 
                communities to educate parents and other caretakers of 
                teens on--
                            ``(i) how to educate teens about opioid and 
                        heroin abuse;
                            ``(ii) how to intervene if a parent thinks 
                        or knows their teen is abusing opioids or 
                        heroin;
                            ``(iii) signs of opioid or heroin overdose; 
                        and
                            ``(iv) the use of naloxone to prevent death 
                        from opioid or heroin overdose;
                    ``(B) the development of detailed digital and print 
                educational materials to accompany the online and 
                social media materials and toolkit described in 
                subparagraph (A);
                    ``(C) the development and dissemination of public 
                service announcements to--
                            ``(i) raise awareness of heroin and opioid 
                        abuse among parents and other caretakers;
                            ``(ii) motivate parents and other 
                        caretakers to visit online educational 
                        materials on heroin and opioid abuse; and
                            ``(iii) provide information for public 
                        health agencies and nonprofit organizations 
                        that provide overdose reversal and prevention 
                        services and community referrals; and
                    ``(D) the dissemination of educational materials to 
                the media through--
                            ``(i) a town hall or panel discussion with 
                        experts;
                            ``(ii) a press release;
                            ``(iii) an online news release;
                            ``(iv) a media tour; and
                            ``(v) sharable infographics;
            ``(2) prevention efforts focused on teenagers, young 
        adults, and college students, including the development of--
                    ``(A) a national digital campaign;
                    ``(B) a community education toolkit for use by 
                community coalitions;
                    ``(C) evidence-based resources for prevention and 
                treatment professionals targeting individuals who are 
                between 18 and 24 years of age, including college 
                students; and
                    ``(D) technical support centers for prevention and 
                treatment professionals, elementary and secondary 
                school-based professionals, and college-based 
                professionals, including recovery staff, to implement 
                and sustain evidence-based educational and prevention 
                programs;
            ``(3) campaigns to inform individuals about available 
        resources to aid in recovery from substance use disorder;
            ``(4) encouragement of individuals in or seeking recovery 
        from substance use disorder to enter the health care system; or
            ``(5) adult-focused awareness efforts, including efforts 
        focused on older adults, relating to prescription medication 
        disposal, opioid and heroin abuse, signs of overdose, and the 
        use of naloxone for reversal.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Attorney General may 
                require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) describe the evidence-based methodology and 
                outcome measurements that will be used to evaluate the 
                program funded with a grant under this section;
                    ``(B) specifically explain how the measurements 
                described in subparagraph (A) will provide valid 
                measures of the impact of the program described in 
                subparagraph (A);
                    ``(C) describe how the program described in 
                subparagraph (A) could be broadly replicated if 
                demonstrated to be effective;
                    ``(D) demonstrate that all planned services will be 
                research-informed, which may include evidence-based 
                practices documented in--
                            ``(i) the report of the Institute of 
                        Medicine entitled `Preventing Mental, 
                        Emotional, and Behavioral Disorders Among Young 
                        People'; or
                            ``(ii) the National Registry of Effective 
                        Programs and Practices (commonly referred to as 
                        `NREPP') of the Substance Abuse and Mental 
                        Health Administration; and
                    ``(E) demonstrate that the eligible entity will 
                effectively integrate and sustain the program described 
                in subparagraph (A) into curriculum or community 
                outreach efforts.
    ``(d) Use of Funds.--A grantee shall use a grant received under 
this section for expenses of educational efforts to--
            ``(1) prevent abuse of opioids, heroin, alcohol, and other 
        drugs; or
            ``(2) promote treatment and recovery.
    ``(e) Duration.--The Attorney General shall award grants under this 
section for a period not to exceed 2 years.
    ``(f) Priority Consideration With Respect to States.--In awarding 
grants to States under this section, the Attorney General shall give 
priority to a State that provides civil liability protection for first 
responders, health professionals, and family members administering 
naloxone to counteract opioid overdoses by--
            ``(1) enacting legislation that provides such civil 
        liability protection; or
            ``(2) providing a certification by the attorney general of 
        the State that the attorney general has--
                    ``(A) reviewed any applicable civil liability 
                protection law to determine the applicability of the 
                law with respect to first responders, health care 
                professionals, family members, and other individuals 
                who may administer naloxone to individuals reasonably 
                believed to be suffering from opioid overdose; and
                    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.
    ``(g) Information Sharing.--The Office of the Attorney General, in 
coordination with the Substance Abuse and Mental Health Services 
Administration and the Department of Education, shall review existing 
evidence-based programs and emerging practices and programs and provide 
information to schools and communities about such programs and 
practices.
    ``(h) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $2,500,000 for each of fiscal 
years 2016 through 2020.''.

SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS LOCAL 
              DRUG CRISES.

    Part MM of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968, as added by section 102, is amended by adding at the end 
the following:

``SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS 
              LOCAL DRUG CRISES.

    ``(a) Definitions.--In this section--
            ``(1) the term `Drug-Free Communities Act of 1997' means 
        chapter 2 of the National Narcotics Leadership Act of 1988 (21 
        U.S.C. 1521 et seq.);
            ``(2) the term `eligible entity' means an organization 
        that--
                    ``(A) on or before the date of submitting an 
                application for a grant under this section, receives or 
                has received a grant under the Drug-Free Communities 
                Act of 1997; and
                    ``(B) has documented, using local data, rates of 
                abuse of opioids at levels that are--
                            ``(i) significantly higher than the 
                        national average as determined by the Attorney 
                        General (including appropriate consideration of 
                        the Monitoring the Future Survey published by 
                        the National Institute on Drug Abuse and the 
                        National Survey on Drug Use and Health by the 
                        Substance Abuse and Mental Health Service 
                        Administration); or
                            ``(ii) higher than the national average, as 
                        determined by the Attorney General (including 
                        appropriate consideration of the surveys 
                        described in clause (i)), over a sustained 
                        period of time; and
            ``(3) the term `local drug crisis' means, with respect to 
        the area served by an eligible entity--
                    ``(A) a sudden increase in the abuse of opioids, as 
                documented by local data; or
                    ``(B) the abuse of prescription medications, 
                specifically opioids, that is significantly higher than 
                the national average, over a sustained period of time, 
                as documented by local data.
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Director, may make grants to eligible entities to implement 
comprehensive community-wide strategies that address local drug crises 
within the area served by the eligible entity.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General at such time, in such manner, and accompanied by such 
        information as the Attorney General may require.
            ``(2) Criteria.--As part of an application for a grant 
        under this section, the Attorney General shall require an 
        eligible entity to submit a detailed, comprehensive, multi-
        sector plan for addressing the local drug crisis within the 
        area served by the eligible entity.
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section--
            ``(1) for programs designed to implement comprehensive 
        community-wide prevention strategies to address local drug 
        crisis in the area served by the eligible entity, in accordance 
        with the plan submitted under subsection (c)(2); and
            ``(2) to obtain specialized training and technical 
        assistance from the organization funded under section 4 of 
        Public Law 107-82 (21 U.S.C. 1521 note).
    ``(e) Grant Amounts and Duration.--
            ``(1) Amounts.--The Attorney General may not award a grant 
        under this section for a fiscal year in an amount that 
        exceeds--
                    ``(A) the amount of non-Federal funds raised by the 
                eligible entity, including in-kind contributions, for 
                that fiscal year; or
                    ``(B) $75,000.
            ``(2) Duration.--The Attorney General shall award grants 
        under this section for a period not to exceed 4 years.
    ``(f) Supplement Not Supplant.--An eligible entity shall use 
Federal funds received under this section only to supplement the funds 
that would, in the absence of those Federal funds, be made available 
from other Federal and non-Federal sources for the activities described 
in this section, and not to supplant those funds.
    ``(g) Evaluation.--A grant under this section shall be subject to 
the same evaluation requirements and procedures as the evaluation 
requirements and procedures imposed on the recipient of a grant under 
the Drug-Free Communities Act of 1997.
    ``(h) Limitation on Administrative Expenses.--Not more than 8 
percent of the amounts made available pursuant to subsection (i) for a 
fiscal year may be used by the Attorney General to pay for 
administrative expenses.
    ``(i) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,000,000 for each of fiscal 
years 2016 through 2020.''.

                TITLE II--LAW ENFORCEMENT AND TREATMENT

SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION PROGRAMS.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 103, is amended by adding at the end the 
following:

``SEC. 3034. TREATMENT ALTERNATIVE TO INCARCERATION PROGRAMS.

    ``(a) Definitions.--In this section--
            ``(1) the term `eligible entity' means a State, unit of 
        local government, Indian tribe, or nonprofit organization; and
            ``(2) the term `eligible participant' means an individual 
        who--
                    ``(A) comes into contact with the juvenile justice 
                system or criminal justice system or is arrested or 
                charged with an offense;
                    ``(B) has a history of or a current--
                            ``(i) substance use disorder;
                            ``(ii) mental illness; or
                            ``(iii) co-occurring mental illness and 
                        substance use disorders; and
                    ``(C) has been approved for participation in a 
                program funded under this section by, as applicable 
                depending on the stage of the criminal justice process, 
                the relevant law enforcement agency or prosecuting 
                attorney, defense attorney, probation or corrections 
                official, judge, or representative from the relevant 
                mental health or substance abuse agency.
    ``(b) Program Authorized.--The Attorney General may make grants to 
eligible entities to develop, implement, or expand a treatment 
alternative to incarceration program for eligible participants, 
including--
            ``(1) pre-booking treatment alternative to incarceration 
        programs, including--
                    ``(A) law enforcement training on substance use 
                disorders, mental illness, and co-occurring mental 
                illness and substance use disorders;
                    ``(B) receiving centers as alternatives to 
                incarceration of eligible participants;
                    ``(C) specialized response units for calls related 
                to substance use disorders, mental illness, and co-
                occurring mental illness and substance use disorders; 
                and
                    ``(D) other arrest and pre-booking treatment 
                alternative to incarceration models; and
            ``(2) post-booking treatment alternative to incarceration 
        programs, including--
                    ``(A) specialized clinical case management;
                    ``(B) pre-trial services related to substances use 
                disorders, mental illness, and co-occurring mental 
                illness and substance use disorders;
                    ``(C) prosecutor and defender based programs;
                    ``(D) specialized probation;
                    ``(E) programs utilizing the American Society of 
                Addiction Medicine patient placement criteria;
                    ``(F) treatment and rehabilitation programs and 
                recovery support services; and
                    ``(G) drug courts, DWI courts, and veterans 
                treatment courts.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Attorney General may 
                require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) provide extensive evidence of collaboration 
                with State and local government agencies overseeing 
                health, community corrections, courts, prosecution, 
                substance abuse, mental health, victims services, and 
                employment services, and with local law enforcement 
                agencies;
                    ``(B) demonstrate consultation with the Single 
                State Authority for Substance Abuse;
                    ``(C) demonstrate that evidence-based treatment 
                practices will be utilized; and
                    ``(D) demonstrate that evidenced-based screening 
                and assessment tools will be utilized to place 
                participants in the treatment alternative to 
                incarceration program.
    ``(d) Requirements.--Each eligible entity awarded a grant for a 
treatment alternative to incarceration program under this section 
shall--
            ``(1) determine the terms and conditions of participation 
        in the program by eligible participants, taking into 
        consideration the collateral consequences of an arrest, 
        prosecution, or criminal conviction;
            ``(2) ensure that each substance abuse and mental health 
        treatment component is licensed and qualified by the relevant 
        jurisdiction;
            ``(3) for programs described in subsection (b)(2), organize 
        an enforcement unit comprised of appropriately trained law 
        enforcement professionals under the supervision of the State, 
        tribal, or local criminal justice agency involved, the duties 
        of which shall include--
                    ``(A) the verification of addresses and other 
                contacts of each eligible participant who participates 
                or desires to participate in the program; and
                    ``(B) if necessary, the location, apprehension, 
                arrest, and return to court of an eligible participant 
                in the program who has absconded from the facility of a 
                treatment provider or has otherwise violated the terms 
                and conditions of the program, consistent with Federal 
                and State confidentiality requirements;
            ``(4) notify the relevant criminal justice entity if any 
        eligible participant in the program absconds from the facility 
        of the treatment provider or otherwise violates the terms and 
        conditions of the program, consistent with Federal and State 
        confidentiality requirements;
            ``(5) submit periodic reports on the progress of treatment 
        or other measured outcomes from participation in the program of 
        each eligible offender participating in the program to the 
        relevant State, tribal, or local criminal justice agency;
            ``(6) describe the evidence-based methodology and outcome 
        measurements that will be used to evaluate the program, and 
        specifically explain how such measurements will provide valid 
        measures of the impact of the program; and
            ``(7) describe how the program could be broadly replicated 
        if demonstrated to be effective.
    ``(e) Use of Funds.--An eligible entity shall use a grant received 
under this section for expenses of a treatment alternative to 
incarceration program, including--
            ``(1) salaries, personnel costs, equipment costs, and other 
        costs directly related to the operation of the program, 
        including the enforcement unit;
            ``(2) payments for treatment providers that are approved by 
        the relevant State or tribal jurisdiction and licensed, if 
        necessary, to provide needed treatment to eligible offenders 
        participating in the program, including medication assisted 
        treatment, aftercare supervision, vocational training, 
        education, and job placement; and
            ``(3) payments to public and nonprofit private entities 
        that are approved by the State or tribal jurisdiction and 
        licensed, if necessary, to provide alcohol and drug addiction 
        treatment and mental health treatment to eligible offenders 
        participating in the program.
    ``(f) Supplement Not Supplant.--An eligible entity shall use 
Federal funds received under this section only to supplement the funds 
that would, in the absence of those Federal funds, be made available 
from other Federal and non-Federal sources for the activities described 
in this section, and not to supplant those funds.
    ``(g) Geographic Distribution.--The Attorney General shall ensure 
that, to the extent practicable, the geographical distribution of 
grants under this section is equitable and includes a grant to an 
eligible entity in--
            ``(1) each State;
            ``(2) rural, suburban, and urban areas; and
            ``(3) tribal jurisdictions.
    ``(h) Priority Consideration With Respect to States.--In awarding 
grants to States under this section, the Attorney General shall give 
priority to a State that provides civil liability protection for first 
responders, health professionals, and family members administering 
naloxone to counteract opioid overdoses by--
            ``(1) enacting legislation that provides such civil 
        liability protection; or
            ``(2) providing a certification by the attorney general of 
        the State that the attorney general has--
                    ``(A) reviewed any applicable civil liability 
                protection law to determine the applicability of the 
                law with respect to first responders, health care 
                professionals, family members, and other individuals 
                who may administer naloxone to individuals reasonably 
                believed to be suffering from opioid overdose; and
                    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.
    ``(i) Reports and Evaluations.--
            ``(1) In general.--Each fiscal year, each recipient of a 
        grant under this section during that fiscal year shall submit 
        to the Attorney General a report on the outcomes of activities 
        carried out using that grant in such form, containing such 
        information, and on such dates as the Attorney General shall 
        specify.
            ``(2) Contents.--A report submitted under paragraph (1) 
        shall--
                    ``(A) describe best practices for treatment 
                alternatives; and
                    ``(B) identify training requirements for law 
                enforcement officers who participate in treatment 
                alternative to incarceration programs.
    ``(j) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,000,000 for each of fiscal 
years 2016 through 2020.''.

SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND IMPLEMENTATION 
              DEMONSTRATION.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 201, is amended by adding at the end the 
following:

``SEC. 3035. LAW ENFORCEMENT NALOXONE TRAINING AND IMPLEMENTATION 
              DEMONSTRATION.

    ``(a) Definition.--In this section, the term `eligible entity' 
means a State, local, or tribal law enforcement agency.
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Secretary of Health and Human Services and the Director of the 
Office of National Drug Control Policy, may make grants to eligible 
entities to create a demonstration law enforcement program to prevent 
opioid and heroin overdose death.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Attorney General may 
                require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) describe the evidence-based methodology and 
                outcome measurements that will be used to evaluate the 
                program funded with a grant under this section, and 
                specifically explain how such measurements will provide 
                valid measures of the impact of the program;
                    ``(B) describe how the program could be broadly 
                replicated if demonstrated to be effective;
                    ``(C) identify the governmental and community 
                agencies that the program will coordinate; and
                    ``(D) describe how law enforcement agencies will 
                coordinate with their corresponding State substance 
                abuse and mental health agencies to identify protocols 
                and resources that are available to victims and 
                families, including information on treatment and 
                recovery resources.
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section to--
            ``(1) make naloxone available to be carried and 
        administered by law enforcement officers;
            ``(2) train and provide resources for law enforcement 
        officers on carrying and administering naloxone for the 
        prevention of opioid and heroin overdose death; and
            ``(3) establish processes, protocols, and mechanisms for 
        referral to treatment.
    ``(e) Grant Amounts and Duration.--
            ``(1) Maximum amount.--The Attorney General may not award a 
        grant under this section in an amount that exceeds $500,000.
            ``(2) Duration.--The Attorney General shall award grants 
        under this section for a period not to exceed 2 years.
    ``(f) Technical Assistance Grants.--The Attorney General shall make 
a grant for the purpose of providing technical assistance and training 
on the use of naloxone to reverse overdose deaths and mechanisms for 
referral to treatment for an eligible entity receiving a grant under 
this section.
    ``(g) Evaluation.--The Attorney General shall conduct an evaluation 
of grants made under this section to determine--
            ``(1) the number of officers equipped with naloxone for the 
        prevention of fatal opioid and heroin overdose;
            ``(2) the number of opioid and heroin overdoses reversed by 
        officers receiving training and supplies of naloxone through a 
        grant received under this section;
            ``(3) the number of calls for service related to opioid and 
        heroin overdose;
            ``(4) the extent to which overdose victims and families 
        receive information about treatment services and available data 
        describing treatment admissions; and
            ``(5) the research, training, and naloxone supply needs of 
        law enforcement and first responder agencies, including those 
        agencies that are not receiving grants under this section.
    ``(h) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,000,000 for each of fiscal 
years 2016 through 2020.''.

SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 202, is amended by adding at the end the 
following:

``SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION.

    ``(a) Definition.--In this section, the term `eligible entity' 
means--
            ``(1) a State, local, or tribal law enforcement agency;
            ``(2) a manufacturer, distributor, or reverse distributor 
        of prescription medications;
            ``(3) a retail pharmacy;
            ``(4) a registered narcotic treatment program;
            ``(5) a hospital or clinic with an on-site pharmacy;
            ``(6) an eligible long-term care facility; or
            ``(7) any other entity authorized by the Drug Enforcement 
        Administration to dispose of prescription medications.
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Administrator of the Drug Enforcement Administration, the 
Secretary of Health and Human Services, and the Director of the Office 
of National Drug Control Policy, may make grants to eligible entities 
to expand or make available disposal sites for unwanted prescription 
medications.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Attorney General may 
                require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) describe the evidence-based methodology and 
                outcome measurements that will be used to evaluate the 
                program funded with a grant under this section, and 
                specifically explain how such measurements will provide 
                valid measures of the impact of the program;
                    ``(B) describe how the program could be broadly 
                replicated if demonstrated to be effective; and
                    ``(C) identify the governmental and community 
                agencies that will coordinate the program.
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section for--
            ``(1) expenses of a prescription drug disposal site, 
        including materials and resources;
            ``(2) implementing disposal procedures and processes;
            ``(3) implementing community education strategies, 
        including community education materials and resources;
            ``(4) replicating a prescription drug take back initiative 
        throughout multiple jurisdictions; and
            ``(5) training of law enforcement officers and other 
        community participants.
    ``(e) Grant Amounts and Duration.--
            ``(1) Maximum amount.--The Attorney General may not award a 
        grant under this section in an amount that exceeds $250,000.
            ``(2) Duration.--The Attorney General shall award grants 
        under this section for a period not to exceed 2 years.
    ``(f) Technical Assistance Grant.--The Attorney General shall make 
a grant to a national nonprofit organization to provide technical 
assistance and training for an eligible entity receiving a grant under 
this section.
    ``(g) Evaluation.--
            ``(1) In general.--The Attorney General shall make a grant 
        for evaluation of the performance of each eligible entity 
        receiving a grant under this section.
            ``(2) Reports.--Each fiscal year, the recipient of a grant 
        under this subsection shall submit to the Attorney General a 
        report that evaluates--
                    ``(A) the effectiveness of the prescription drug 
                take back program of each eligible entity receiving a 
                grant under this section; and
                    ``(B) the effect of disposal efforts on drug 
                circulation.
    ``(h) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $2,500,000 for each of fiscal 
years 2016 through 2020.''.

                   TITLE III--TREATMENT AND RECOVERY

SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND INTERVENTIONS 
              DEMONSTRATION.

    Subpart 1 of part B of title V of the Public Health Service Act (42 
U.S.C. 290bb et seq.) is amended--
            (1) by redesignating section 514 (42 U.S.C. 290bb-9), as 
        added by section 3632 of the Methamphetamine Anti-Proliferation 
        Act of 2000 (Public Law 106-310; 114 Stat. 1236), as section 
        514B; and
            (2) by adding at the end the following:

``SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.

    ``(a) Grants.--
            ``(1) Authority to make grants.--The Director of the Center 
        for Substance Abuse Treatment (referred to in this section as 
        the `Director') may award grants to State substance abuse 
        agencies, units of local government, nonprofit organizations, 
        and Indian tribes or tribal organizations (as defined in 
        section 4 of the Indian Health Care Improvement Act (25 U.S.C. 
        1603)) that have a high rate, or have had a rapid increase, in 
        the use of heroin or other opioids, in order to permit such 
        entities to expand activities, including an expansion in the 
        availability of medication assisted treatment, with respect to 
        the treatment of addiction in the specific geographical areas 
        of such entities where there is a rate or rapid increase in the 
        use of heroin or other opioids.
            ``(2) Recipients.--The entities receiving grants under 
        paragraph (1) shall be selected by the Director.
            ``(3) Nature of activities.--The grant funds awarded under 
        paragraph (1) shall be used for activities that are based on 
        reliable scientific evidence of efficacy in the treatment of 
        problems related to heroin or other opioids.
    ``(b) Geographic Distribution.--The Director shall ensure that 
grants awarded under subsection (a) are distributed equitably among the 
various regions of the Nation and among rural, urban, and suburban 
areas that are affected by the use of heroin or other opioids.
    ``(c) Additional Activities.--The Director shall--
            ``(1) evaluate the activities supported by grants awarded 
        under subsection (a);
            ``(2) disseminate widely such significant information 
        derived from the evaluation as the Director considers 
        appropriate;
            ``(3) provide States, Indian tribes and tribal 
        organizations, and providers with technical assistance in 
        connection with the provision of treatment of problems related 
        to heroin and other opioids; and
            ``(4) fund only those applications that specifically 
        support recovery services as a critical component of the grant 
        program.
    ``(d) Definition.--The term `medication assisted treatment' means 
the use, for problems relating to heroin and other opioids, of 
medications approved by the Food and Drug Administration in combination 
with counseling and behavioral therapies.
    ``(e) Authorization of Appropriations.--
            ``(1) In general.--There are authorized to be appropriated 
        to carry out this section $12,000,000 for fiscal year 2016 and 
        such sums as may be necessary for each of fiscal years 2016 
        through 2020.
            ``(2) Use of certain funds.--Of the funds appropriated to 
        carry out this section in any fiscal year, the lesser of 5 
        percent of such funds or $1,000,000 shall be available to the 
        Director for purposes of carrying out subsection (c).''.

SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 203, is amended by adding at the end the 
following:

``SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.

    ``(a) Definitions.--In this section--
            ``(1) the term `criminal justice agency' means a State, 
        local, or tribal--
                    ``(A) court;
                    ``(B) prison;
                    ``(C) jail; or
                    ``(D) other agency that performs the administration 
                of criminal justice, including prosecution, pretrial 
                services, and community supervision; and
            ``(2) the term `eligible entity' means a State, unit of 
        local government, or Indian tribe.
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Secretary of Health and Human Services and the Director of the 
Office of National Drug Control Policy, may make grants to eligible 
entities to implement medication assisted treatment programs through 
criminal justice agencies.
    ``(c) Application.--
            ``(1) In general.--An eligible entity desiring a grant 
        under this section shall submit an application to the Attorney 
        General--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Attorney General may 
                require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) certify that each medication assisted 
                treatment program funded with a grant under this 
                section has been developed in consultation with the 
                Single State Authority for Substance Abuse; and
                    ``(B) describe how data will be collected and 
                analyzed to determine the effectiveness of the program 
                described in subparagraph (A).
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section for expenses of--
            ``(1) a medication assisted treatment program, including 
        the expenses of prescribing medications recognized by the Food 
        and Drug Administration for opioid treatment in conjunction 
        with psychological and behavioral therapy;
            ``(2) training criminal justice agency personnel and 
        treatment providers on medication assisted treatment;
            ``(3) cross-training personnel providing behavioral health 
        and health services, administration of medicines, and other 
        administrative expenses, including required reports; and
            ``(4) the provision of recovery coaches who are responsible 
        for providing mentorship and transition plans to individuals 
        reentering society following incarceration or alternatives to 
        incarceration.
    ``(e) Grant Amounts and Duration.--
            ``(1) Maximum amount.--The Attorney General may not award a 
        grant under this section in an amount that exceeds $750,000.
            ``(2) Duration.--The Attorney General shall award grants 
        under this section for a period not to exceed 2 years.
    ``(f) Priority Consideration With Respect to States.--In awarding 
grants to States under this section, the Attorney General shall give 
priority to a State that provides civil liability protection for first 
responders, health professionals, and family members administering 
naloxone to counteract opioid overdoses by--
            ``(1) enacting legislation that provides such civil 
        liability protection; or
            ``(2) providing a certification by the attorney general of 
        the State that the attorney general has--
                    ``(A) reviewed any applicable civil liability 
                protection law to determine the applicability of the 
                law with respect to first responders, health care 
                professionals, family members, and other individuals 
                who may administer naloxone to individuals reasonably 
                believed to be suffering from opioid overdose; and
                    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.
    ``(g) Technical Assistance.--The Attorney General, in coordination 
with the Director of the National Institute on Drug Abuse and the 
Secretary of Health and Human Services, shall provide technical 
assistance and training for an eligible entity receiving a grant under 
this section.
    ``(h) Reports.--
            ``(1) In general.--An eligible entity receiving a grant 
        under this subsection shall submit a report to the Attorney 
        General on the outcomes of each grant received under this 
        section for individuals receiving medication assisted 
        treatment, based on--
                    ``(A) the recidivism of the individuals;
                    ``(B) the treatment outcomes of the individuals, 
                including maintaining abstinence from illegal, 
                unauthorized, and unprescribed or undispensed opioids 
                and heroin;
                    ``(C) a comparison of the cost of providing 
                medication assisted treatment to the cost of 
                incarceration or other participation in the criminal 
                justice system;
                    ``(D) the housing status of the individuals; and
                    ``(E) the employment status of the individuals.
            ``(2) Contents and timing.--Each report described in 
        paragraph (1) shall be submitted annually in such form, 
        containing such information, and on such dates as the Attorney 
        General shall specify.
    ``(i) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,000,000 for each of fiscal 
years 2016 through 2020.''.

SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE.

    (a) Definitions.--In this section:
            (1) Eligible entity.--The term ``eligible entity'' means--
                    (A) a high school that has been accredited as a 
                recovery high school by the Association of Recovery 
                Schools;
                    (B) an accredited high school that is seeking to 
                establish or expand recovery support services;
                    (C) an institution of higher education;
                    (D) a recovery program at a nonprofit collegiate 
                institution; or
                    (E) a nonprofit organization.
            (2) Institution of higher education.--The term 
        ``institution of higher education'' has the meaning given the 
        term in section 101 of the Higher Education Act of 1965 (20 
        U.S.C. 1001).
            (3) Recovery program.--The term ``recovery program''--
                    (A) means a program to help individuals who are 
                recovering from substance use disorders to initiate, 
                stabilize, and maintain healthy and productive lives in 
                the community; and
                    (B) includes peer-to-peer support and communal 
                activities to build recovery skills and supportive 
                social networks.
    (b) Grants Authorized.--The ONDCP Recovery Branch, in consultation 
with the Secretary of Education, may award grants to eligible entities 
to enable the entities to--
            (1) provide substance use recovery support services to 
        young people in high school and enrolled in institutions of 
        higher education;
            (2) help build communities of support for young people in 
        recovery through a spectrum of activities such as counseling 
        and healthy and wellness-oriented social activities; and
            (3) encourage initiatives designed to help young people 
        achieve and sustain recovery from substance use disorders.
    (c) Use of Funds.--Grants awarded under subsection (b) may be used 
for activities to develop, support, and maintain youth recovery support 
services, including--
            (1) the development and maintenance of a dedicated physical 
        space for recovery programs;
            (2) dedicated staff for the provision of recovery programs;
            (3) healthy and wellness-oriented social activities and 
        community engagement;
            (4) establishment of recovery high schools;
            (5) coordination of recovery programs with--
                    (A) substance use disorder treatment programs and 
                systems;
                    (B) providers of mental health services;
                    (C) primary care providers;
                    (D) the criminal justice system, including the 
                juvenile justice system;
                    (E) employers;
                    (F) housing services;
                    (G) child welfare services;
                    (H) institutions of secondary higher education and 
                institutions of higher education; and
                    (I) other programs or services related to the 
                welfare of an individual in recovery from a substance 
                use disorder;
            (6) the development of peer-to-peer support programs or 
        services; and
            (7) additional activities that help youths and young adults 
        to achieve recovery from substance use disorders.
    (d) Resource Center.--The ONDCP Recovery Branch shall establish a 
resource center to provide technical support to recipients of grants 
under this section.
    (e) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $3,000,000 for fiscal year 2016 
and each of the 5 succeeding fiscal years.

SEC. 304. BUILDING COMMUNITIES OF RECOVERY.

    (a) Definition.--In this section, the term ``recovery community 
organization'' means an independent nonprofit organization that--
            (1) mobilizes resources within and outside of the recovery 
        community to increase the prevalence and quality of long-term 
        recovery from substance use disorders; and
            (2) is wholly or principally governed by people in recovery 
        for substance use disorders who reflect the community served.
    (b) Grants Authorized.--The ONDCP Recovery Branch, in consultation 
with the Substance Abuse and Mental Health Services Administration, may 
award grants to recovery community organizations to enable such 
organizations to develop, expand, and enhance recovery services.
    (c) Maximum Grant Amount.--The ONDCP Recovery Branch may not award 
a grant under this section in an amount that exceeds $200,000.
    (d) Federal Share.--The Federal share of the costs of a program 
funded by a grant under this section may not exceed 50 percent.
    (e) Use of Funds.--Grants awarded under subsection (b)--
            (1) shall be used to develop, expand, and enhance community 
        and statewide recovery support services; and
            (2) may be used to--
                    (A) advocate for individuals in recovery from 
                substance use disorders;
                    (B) build connections between recovery networks, 
                between recovery community organizations, and with 
                other recovery support services, including--
                            (i) substance use disorder treatment 
                        programs and systems;
                            (ii) providers of mental health services;
                            (iii) primary care providers;
                            (iv) the criminal justice system;
                            (v) employers;
                            (vi) housing services;
                            (vii) child welfare agencies; and
                            (viii) other recovery support services that 
                        facilitate recovery from substance use 
                        disorders;
                    (C) reduce the stigma associated with substance use 
                disorders;
                    (D) conduct public education and outreach on issues 
                relating to substance use disorders and recovery, 
                including--
                            (i) how to identify the signs of addiction;
                            (ii) the resources that are available for 
                        individuals struggling with addiction;
                            (iii) the resources that are available to 
                        help support individuals in recovery; and
                            (iv) information on the medical 
                        consequences of substance use disorders, 
                        including neonatal abstinence syndrome and 
                        potential infection with human immunodeficiency 
                        virus and viral hepatitis; and
                    (E) carry out other activities that strengthen the 
                network of community support for individuals in 
                recovery.
    (f) Resource Center.--The ONDCP Recovery Branch shall establish a 
resource center to provide technical assistance to recipients of grants 
under this section and to provide information to individuals seeking to 
support people in recovery from substance use disorders.
    (g) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,700,000 in fiscal year 2016 
and each of the 3 succeeding fiscal years.

              TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.

    Title I of the Omnibus Crime Control and Safe Streets Act of 1968 
(42 U.S.C. 3711 et seq.) is amended--
            (1) by redesignating part KK as part LL;
            (2) by redesignating sections 3011 and 3012 as sections 
        3021 and 3022, respectively; and
            (3) by inserting before part LL, as redesignated, the 
        following:

     ``PART KK--CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM

``SEC. 3011. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.

    ``(a) Definition.--In this section, the term `eligible entity' 
means a State, unit of local government, nonprofit organization, or 
Indian tribe.
    ``(b) Grant Program Authorized.--The Attorney General may make 
grants of not more than $750,000 to eligible entities to design, 
implement, and expand educational programs for offenders in prisons, 
jails, and juvenile facilities, including to pay for--
            ``(1) basic education, secondary level academic education, 
        high school equivalency examination preparation, career 
        technical education, and English as a second language 
        instruction at the basic, secondary, or post-secondary levels, 
        for adult and juvenile populations;
            ``(2) screening and assessment of inmates to assess 
        education level, needs, occupational interest or aptitude, risk 
        level, and other needs, and case management services;
            ``(3) hiring and training of instructors and aides, 
        reimbursement of non-corrections staff and experts, 
        reimbursement of stipends paid to inmate tutors or aides, and 
        the costs of training inmate tutors and aides;
            ``(4) instructional supplies and equipment, including 
        occupational program supplies and equipment to the extent that 
        the supplies and equipment are used for instructional purposes;
            ``(5) partnerships and agreements with community colleges, 
        universities, and career technology education program 
        providers, including tuition payments;
            ``(6) certification programs providing recognized high 
        school equivalency certificates and industry recognized 
        credentials; and
            ``(7) technology solutions to--
                    ``(A) meet the instructional, assessment, and 
                information needs of correctional populations; and
                    ``(B) facilitate the continued participation of 
                incarcerated students in community-based education 
                programs after the students are released from 
                incarceration.
    ``(c) Application.--An eligible entity desiring a grant under this 
section shall submit to the Attorney General an application in such 
form and manner, at such time, and accompanied by such information as 
the Attorney General specifies.
    ``(d) Priority Considerations.--In awarding grants under this 
section, the Attorney General shall give priority to applicants that--
            ``(1) assess the level of risk and need of inmates, 
        including by--
                    ``(A) assessing the need for English as a second 
                language instruction;
                    ``(B) conducting educational assessments; and
                    ``(C) assessing occupational interests and 
                aptitudes;
            ``(2) target educational services to assessed needs, 
        including academic and occupational at the basic, secondary, or 
        post-secondary level;
            ``(3) target career technology education programs to--
                    ``(A) areas of identified occupational demand; and
                    ``(B) employment opportunities in the communities 
                in which students are reasonably expected to reside 
                post-release;
            ``(4) include a range of appropriate educational 
        opportunities at the basic, secondary, and post-secondary 
        levels;
            ``(5) include opportunities for students to attain industry 
        recognized credentials;
            ``(6) include partnership or articulation agreements 
        linking institutional education programs with community sited 
        programs provided by adult education program providers and 
        accredited institutions of higher education, community 
        colleges, and vocational training institutions; and
            ``(7) explicitly include career pathways models offering 
        opportunities for incarcerated students to develop academic 
        skills, in-demand occupational skills and credentials, 
        occupational experience in institutional work programs or work 
        release programs, and linkages with employers in the community, 
        so that incarcerated students have opportunities to embark on 
        careers with strong prospects for both post-release employment 
        and advancement in a career ladder over time.
    ``(e) Requirements.--An eligible entity desiring a grant under this 
section shall--
            ``(1) describe the evidence-based methodology and outcome 
        measurements that will be used to evaluate each program funded 
        with a grant under this section, and specifically explain how 
        such measurements will provide valid measures of the impact of 
        the program; and
            ``(2) describe how the program described in paragraph (1) 
        could be broadly replicated if demonstrated to be effective.
    ``(f) Control of Internet Access.--An entity that receives a grant 
under this section shall restrict access to the Internet by prisoners, 
as appropriate, to ensure public safety.

``SEC. 3012. AUTHORIZATION OF APPROPRIATIONS.

    ``There are authorized to be appropriated $5,000,000 to carry out 
this part for fiscal years 2016 through 2020.''.

SEC. 402. REVISION OF FAFSA FORM.

    Section 483 of the Higher Education Act of 1965 (20 U.S.C. 1090) is 
amended by adding at the end the following:
    ``(i) Convictions.--The Secretary shall not include any question 
about the conviction of an applicant for the possession or sale of 
illegal drugs on the FAFSA (or any other form developed under 
subsection (a)).''.

SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COLLATERAL CONSEQUENCES.

    (a) Definition.--In this section, the term ``collateral 
consequence'' means a penalty, disability, or disadvantage--
            (1) imposed on an individual as a result of a criminal 
        conviction but not as part of the judgment of the court that 
        imposes the conviction; or
            (2) that an administrative agency, official, or civil court 
        is authorized, but not required, to impose on an individual 
        convicted of a felony, misdemeanor, or other criminal offense.
    (b) Establishment.--
            (1) In general.--Not later than 30 days after the date of 
        enactment of this Act, the Secretary of Health and Human 
        Services (in this section referred to as the ``Secretary'') 
        shall establish a bipartisan task force to be known as the Task 
        Force on Recovery and Collateral Consequences (in this section 
        referred to as the ``Task Force'').
            (2) Membership.--
                    (A) Total number of members.--The Task Force shall 
                include 10 members, who shall be appointed by the 
                Secretary in accordance with subparagraphs (B) and (C).
                    (B) Members of the task force.--The Task Force 
                shall include--
                            (i) members who have national recognition 
                        and significant expertise in areas such as 
                        health care, housing, employment, substance use 
                        disorder, mental health, law enforcement, and 
                        law;
                            (ii) not fewer than 2 members--
                                    (I) who have personally experienced 
                                substance abuse or addiction and are in 
                                recovery; and
                                    (II) not fewer than 1 one of whom 
                                has benefited from medication assisted 
                                treatment; and
                            (iii) to the extent practicable, members 
                        who formerly served as elected officials at the 
                        State and Federal levels.
                    (C) Timing.--The Secretary shall appoint the 
                members of the Task Force not later than 60 days after 
                the date on which the Task Force is established under 
                paragraph (1).
            (3) Chairperson.--The Task Force shall select a chairperson 
        or co-chairpersons from among the members of the Task Force.
    (c) Duties of the Task Force.--
            (1) In general.--The Task Force shall--
                    (A) identify collateral consequences for 
                individuals with Federal or State drug convictions who 
                are in recovery for substance use disorder; and
                    (B) determine whether the collateral consequences 
                identified under subparagraph (A) unnecessarily delay 
                individuals in recovery from resuming their personal 
                and professional activities.
            (2) Recommendations.--Not later than 180 days after the 
        date of the first meeting of the Task Force, the Task Force 
        shall develop recommendations for proposed legislative and 
        regulatory changes to reduce and, to the extent practicable, 
        eliminate the collateral consequences identified by the Task 
        Force under paragraph (1).
            (3) Collection of information.--The Task Force shall hold 
        hearings, require the testimony and attendance of witnesses, 
        and secure information from any department or agency of the 
        United States in performing the duties under paragraphs (1) and 
        (2).
            (4) Report.--Not later than 1 year after the date of the 
        first meeting of the Task Force, the Task Force shall submit a 
        report detailing the findings and recommendations of the Task 
        Force to--
                    (A) each relevant committee of Congress;
                    (B) the head of each relevant department or agency 
                of the United States;
                    (C) the President; and
                    (D) the Vice President.

  TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND 
                                VETERANS

SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS OPIOID AND 
              HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE OFFENDERS.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 302, is amended by adding at the end the 
following:

``SEC. 3038. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS OPIOID 
              AND HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE 
              OFFENDERS.

    ``(a) Definitions.--In this section--
            ``(1) the term `State criminal justice agency' means the 
        agency of the State responsible for administering criminal 
        justice funds, including the Edward Byrne Memorial Justice 
        Assistance Grant Program under subpart 1 of part E; and
            ``(2) the term `State substance abuse agency' means the 
        agency of the State responsible for the State prevention, 
        treatment, and recovery system, including management of the 
        Substance Abuse Prevention and Treatment Block Grant under 
        subpart II of part B of title XIX of the Public Health Service 
        Act (42 U.S.C. 300x-21 et seq.).
    ``(b) Purpose and Program Authority.--
            ``(1) Grant authorization.--The Attorney General, in 
        coordination with the Secretary of Health and Human Services, 
        may award competitive grants jointly to a State substance abuse 
        agency and a State criminal justice agency to address the use 
        of opioids and heroin among pregnant and parenting female 
        offenders in the State to promote public safety, public health, 
        family permanence, and well-being.
            ``(2) Purposes and program authority.--A grant under this 
        section shall be used to facilitate or enhance collaboration 
        between the State criminal justice and State substance abuse 
        systems in order to carry out programs to address the use of 
        opioid and heroin abuse by pregnant and parenting female 
        offenders.
    ``(c) Applications.--
            ``(1) In general.--A State substance abuse agency and State 
        criminal justice agency desiring a grant under this section 
        shall jointly submit to the Attorney General an application in 
        such form, and containing such information, as the Attorney 
        General may prescribe by regulation or guidelines.
            ``(2) Contents.--
                    ``(A) In general.--Each application for a grant 
                under this section shall contain a plan to expand the 
                services of the State for pregnant and parenting female 
                offenders for the use of opioids, heroin, and other 
                drugs, which shall be in accordance with regulations or 
                guidelines established by the Attorney General, in 
                consultation with the Secretary of Health and Human 
                Services.
                    ``(B) Plan.--A plan submitted under subparagraph 
                (A) shall, at a minimum, include--
                            ``(i) a description of how the applicants 
                        will work jointly to address the needs 
                        associated with the use of opioids or heroin by 
                        pregnant and parenting female offenders to 
                        promote family stability and permanence;
                            ``(ii) a description of the nature and the 
                        extent of the problem of opioid and heroin use 
                        by pregnant and parenting female offenders in 
                        the State;
                            ``(iii) a certification that the State has 
                        involved counties and other units of local 
                        government, when appropriate, in the 
                        development, expansion, modification, 
                        operation, or improvement of proposed programs 
                        to address the problems associated with opioid 
                        and heroin use;
                            ``(iv) a certification that funds received 
                        under this section will be used to supplement, 
                        not supplant, other Federal, State, and local 
                        funds; and
                            ``(v) a description of clinically 
                        appropriate practices and procedures to--
                                    ``(I) screen and assess pregnant 
                                and parenting female offenders for 
                                problems associated with opioids and 
                                heroin;
                                    ``(II) screen and assess pregnant 
                                and parenting female offenders 
                                demonstrating problems associated with 
                                opioids and heroin for co-occurring 
                                mental disorders;
                                    ``(III) provide clinically 
                                appropriate services, including 
                                medication assisted treatment, for 
                                female offenders and their children in 
                                the same location to promote family 
                                permanence and self-sufficiency; and
                                    ``(IV) provide for a process to 
                                enhance or ensure the abilities of the 
                                State criminal justice agency and State 
                                substance abuse agency to work together 
                                to reunite families when appropriate in 
                                the case where family treatment is not 
                                provided.
    ``(d) Period of Grant; Renewal.--
            ``(1) Period.--A grant under this section shall be for a 
        period of 3 years.
            ``(2) Renewal.--A State substance abuse agency and a State 
        criminal justice agency receiving a grant under this section 
        may apply for and, after the end of the period of the first 
        grant under this section, receive 1 additional grant under this 
        section.
    ``(e) Performance Accountability; Reports.--
            ``(1) Reports.--A State substance abuse agency and a State 
        criminal justice agency receiving a grant under this section 
        shall jointly submit to the Attorney General a report on the 
        activities carried out under the grant at the end of each 
        fiscal year during the period of the grant.
            ``(2) Evaluation.--Not later than 1 year after the end of 
        the period of a grant under this section, the Attorney General 
        shall submit a report to each committee of Congress with 
        jurisdiction of the program under this section that summarizes 
        the reports of the recipients of the grant and provides 
        recommendations, if any, for further legislative action.
    ``(f) Training and Technical Assistance.--The Attorney General 
shall support State substance abuse and State criminal justice agencies 
by developing, in consultation with State substance abuse and State 
criminal justice agencies, and offering a program of training and 
technical assistance to assist the agencies in developing programs and 
protocols--
            ``(1) to implement this section; and
            ``(2) for effectively working across the Federal and State 
        criminal and substance abuse systems.
    ``(g) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $5,000,000 for each of fiscal 
years 2016 through 2020.''.

SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE TREATMENT.

    Section 2925 of the Omnibus Crime Control and Safe Streets Act of 
1968 (42 U.S.C. 3797s-4) is amended--
            (1) by striking ``An entity'' and inserting ``(a) Entity 
        Reports.--An entity''; and
            (2) by adding at the end the following:
    ``(b) Attorney General Report on Family-Based Substance Abuse 
Treatment.--The Attorney General shall submit to Congress an annual 
report that describes the number of grants awarded under section 
2921(1) and how such grants are used by the recipients for family-based 
substance abuse treatment programs that serve as alternatives to 
incarceration for custodial parents to receive treatment and services 
as a family.''.

SEC. 503. VETERANS' TREATMENT COURTS.

    Section 2991 of the Omnibus Crime Control and Safe Streets Act of 
1968 (42 U.S.C. 3797aa) is amended--
            (1) by redesignating subsection (i) as subsection (j);
            (2) by inserting after subsection (h) the following:
    ``(i) Assisting Veterans.--
            ``(1) Definitions.--In this subsection:
                    ``(A) Peer to peer services or programs.--The term 
                `peer to peer services or programs' means services or 
                programs that connect qualified veterans with other 
                veterans for the purpose of providing support and 
                mentorship to assist qualified veterans in obtaining 
                treatment, recovery, stabilization, or rehabilitation.
                    ``(B) Qualified veteran.--The term `qualified 
                veteran' means a preliminarily qualified offender who--
                            ``(i) has served on active duty in any 
                        branch of the Armed Forces, including the 
                        National Guard and reserve components; and
                            ``(ii)(I) was discharged or released from 
                        such service under conditions other than 
                        dishonorable; or
                            ``(II) was discharged or released from such 
                        service under dishonorable conditions, if the 
                        reason for that discharge or release, if known, 
                        is attributable to drug use.
                    ``(C) Veterans treatment court program.--The term 
                `veterans treatment court program' means a court 
                program involving collaboration among criminal justice, 
                veterans, and mental health and substance abuse 
                agencies that provides qualified veterans with--
                            ``(i) intensive judicial supervision and 
                        case management, which may include random and 
                        frequent drug testing where appropriate;
                            ``(ii) a full continuum of treatment 
                        services, including mental health services, 
                        substance abuse services, medical services, and 
                        services to address trauma;
                            ``(iii) alternatives to incarceration; and
                            ``(iv) other appropriate services, 
                        including housing, transportation, mentoring, 
                        employment, job training, education, and 
                        assistance in applying for and obtaining 
                        available benefits.
            ``(2) Veterans assistance program.--
                    ``(A) In general.--The Attorney General, in 
                consultation with the Secretary of Veterans Affairs, 
                may award grants under this subsection to applicants to 
                establish or expand--
                            ``(i) veterans treatment court programs;
                            ``(ii) peer to peer services or programs 
                        for qualified veterans;
                            ``(iii) practices that identify and provide 
                        treatment, rehabilitation, legal, transitional, 
                        and other appropriate services to qualified 
                        veterans who have been incarcerated; and
                            ``(iv) training programs to teach criminal 
                        justice, law enforcement, corrections, mental 
                        health, and substance abuse personnel how to 
                        identify and appropriately respond to incidents 
                        involving qualified veterans.
                    ``(B) Priority.--In awarding grants under this 
                subsection, the Attorney General shall give priority to 
                applications that--
                            ``(i) demonstrate collaboration between and 
                        joint investments by criminal justice, mental 
                        health, substance abuse, and veterans service 
                        agencies;
                            ``(ii) promote effective strategies to 
                        identify and reduce the risk of harm to 
                        qualified veterans and public safety; and
                            ``(iii) propose interventions with 
                        empirical support to improve outcomes for 
                        qualified veterans.''; and
            (3) in subsection (j), as so redesignated--
                    (A) by redesignating paragraph (2) as paragraph 
                (3); and
                    (B) by inserting after paragraph (1) the following:
            ``(2) Veterans treatment courts.--In addition to the 
        amounts authorized under paragraph (1), there are authorized to 
        be appropriated to the Attorney General $5,000,000 for each of 
        fiscal years 2016 through 2020 to carry out subsection (i).''.

  TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS 
                        OPIOID AND HEROIN ABUSE

SEC. 601. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID ABUSE 
              RESPONSE.

    Part MM of the Omnibus Crime Control and Safe Streets Act of 1968, 
as amended by section 501, is amended by adding at the end the 
following:

``SEC. 3039. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID ABUSE 
              RESPONSE.

    ``(a) Definitions.--In this section--
            ``(1) the term `dispenser' has the meaning given the term 
        in section 102 of the Controlled Substances Act (21 U.S.C. 
        802);
            ``(2) the term `prescriber of a schedule II, III, or IV 
        controlled substance' does not include a prescriber of a 
        schedule II, III, or IV controlled substance that dispenses the 
        substance--
                    ``(A) for use on the premises on which the 
                substance is dispensed;
                    ``(B) in a hospital emergency room, when the 
                substance is in short supply;
                    ``(C) for a certified opioid treatment program; or
                    ``(D) in other situations as the Attorney General 
                may reasonably determine;
            ``(3) the term `prescriber' means a dispenser who 
        prescribes a controlled substance, or the agent of such a 
        dispenser; and
            ``(4) the term `schedule II, III, or IV controlled 
        substance' means a controlled substance that is listed on 
        schedule II, schedule III, or schedule IV of section 202(c) of 
        the Controlled Substances Act (21 U.S.C. 812(c)).
    ``(b) Planning and Implementation Grants.--
            ``(1) In general.--The Attorney General, in coordination 
        with the Secretary of Health and Human Services and the 
        Director of the Office of National Drug Control Policy, may 
        award grants to States, and combinations thereof, to prepare a 
        comprehensive plan for and implement an integrated opioid abuse 
        response initiative.
            ``(2) Purposes.--A State receiving a grant under this 
        section shall establish a comprehensive response to opioid 
        abuse, which shall include--
                    ``(A) prevention and education efforts around 
                heroin and opioid use, treatment, and recovery;
                    ``(B) a comprehensive prescription drug monitoring 
                program to track dispensing of schedule II, III, or IV 
                controlled substances, which shall include--
                            ``(i) data sharing with other States by 
                        statute, regulation, or interstate agreement; 
                        and
                            ``(ii) educating physicians, residents, 
                        medical students, and other prescribers of 
                        Schedule II, III, or IV controlled substances 
                        on the prescription drug monitoring program of 
                        the State;
                    ``(C) developing, implementing, or expanding the 
                prescription drug and opioid addiction treatment 
                program of the State by--
                            ``(i) expanding programs for medication 
                        assisted treatment of prescription drug and 
                        opioid addiction, including training for 
                        treatment and recovery support providers;
                            ``(ii) developing, implementing, or 
                        expanding programs for behavioral health 
                        therapy for individuals who are in treatment 
                        for prescription drug and opioid addiction, 
                        including contingency management, cognitive 
                        behavioral therapy, and motivational 
                        enhancements;
                            ``(iii) developing, implementing, or 
                        expanding programs to screen individuals who 
                        are in treatment for prescription drug and 
                        opioid addiction for hepatitis C and HIV, and 
                        provide treatment for those individuals if 
                        clinically appropriate; or
                            ``(iv) developing, implementing, or 
                        expanding programs that provide screening, 
                        early intervention, and referral to treatment 
                        (commonly referred to as `SBIRT') to teenagers 
                        and young adults in primary care, middle 
                        schools, high schools, universities, school-
                        based health centers, and other community-based 
                        health care settings frequently accessed by 
                        teenagers or young adults; and
                    ``(D) developing, implementing, and expanding 
                programs to prevent overdose death of prescription 
                medications and opioids.
            ``(3) Planning grant applications.--
                    ``(A) Application.--
                            ``(i) In general.--A State desiring a 
                        planning grant under this section to prepare a 
                        comprehensive plan for an integrated opioid 
                        abuse response initiative shall submit to the 
                        Attorney General an application in such form, 
                        and containing such information, as the 
                        Attorney General may prescribe by regulation or 
                        guidelines.
                            ``(ii) Requirements.--An application for a 
                        planning grant under this section shall, at a 
                        minimum, include--
                                    ``(I) a budget and a budget 
                                justification for the activities to be 
                                carried out using the grant;
                                    ``(II) a description of the 
                                activities proposed to be carried out 
                                using the grant, including a schedule 
                                for completion of such activities;
                                    ``(III) outcome measures that will 
                                be used to measure the effectiveness of 
                                the programs and initiatives to address 
                                opioids; and
                                    ``(IV) a description of the 
                                personnel necessary to complete such 
                                activities.
                    ``(B) Period; nonrenewability.--A planning grant 
                under this section shall be for a period of 1 year. A 
                State may not receive more than 1 planning grant under 
                this section.
                    ``(C) Amount.--A planning grant under this section 
                may not exceed $100,000, except that the Attorney 
                General may, for good cause, approve a grant in a 
                higher amount.
                    ``(D) Strategic plan and program implementation 
                plan.--A State receiving a planning grant under this 
                section shall develop a strategic plan and a program 
                implementation plan.
            ``(4) Implementation grants.--
                    ``(A) Application.--A State desiring an 
                implementation grant under this section to implement a 
                comprehensive strategy for addressing opioid abuse 
                shall submit to the Attorney General an application in 
                such form, and containing such information, as the 
                Attorney General may prescribe by regulation or 
                guidelines.
                    ``(B) Use of funds.--A State that receives an 
                implementation grant under this section shall use the 
                grant for the cost of carrying out an integrated opioid 
                abuse response program in accordance with this section, 
                including for technical assistance, training, and 
                administrative expenses.
                    ``(C) Requirements.--An integrated opioid abuse 
                response program carried out using an implementation 
                grant under this section shall--
                            ``(i) ensure that each prescriber of a 
                        schedule II, III, or IV controlled substance in 
                        the State--
                                    ``(I) registers with the 
                                prescription drug monitoring program of 
                                the State; and
                                    ``(II) consults the prescription 
                                drug monitoring program database of the 
                                State before prescribing a schedule II, 
                                III, or IV controlled substance;
                            ``(ii) ensure that each dispenser of a 
                        schedule II, III, or IV controlled substance in 
                        the State--
                                    ``(I) registers with the 
                                prescription drug monitoring program of 
                                the State;
                                    ``(II) consults the prescription 
                                drug monitoring program database of the 
                                State before dispensing a schedule II, 
                                III, or IV controlled substance; and
                                    ``(III) reports to the prescription 
                                drug monitoring program of the State, 
                                at a minimum, each instance in which a 
                                schedule II, III, or IV controlled 
                                substance is dispensed, with limited 
                                exceptions, as defined by the State, 
                                which shall indicate the prescriber by 
                                name and National Provider Identifier;
                            ``(iii) require that, not fewer than 4 
                        times each year, the State agency or agencies 
                        that administer the prescription drug 
                        monitoring program of the State prepare and 
                        provide to each prescriber of a schedule II, 
                        III, or IV controlled substance an 
                        informational report that shows how the 
                        prescribing patterns of the prescriber compare 
                        to prescribing practices of the peers of the 
                        prescriber and expected norms;
                            ``(iv) if informational reports provided to 
                        a prescriber under clause (iii) indicate that 
                        the prescriber is repeatedly falling outside of 
                        expected norms or standard practices for the 
                        prescriber's field, direct the prescriber to 
                        educational resources on appropriate 
                        prescribing of controlled substances;
                            ``(v) ensure that the prescriber licensing 
                        board of the State receives a report describing 
                        any prescribers that repeatedly fall outside of 
                        expected norms or standard practices for the 
                        prescriber's field, as described in clause 
                        (iii);
                            ``(vi) require consultation with the Single 
                        State Authority for Substance Abuse; and
                            ``(vii) establish requirements for how data 
                        will be collected and analyzed to determine the 
                        effectiveness of the program.
                    ``(D) Period.--An implementation grant under this 
                section shall be for a period of 2 years.
                    ``(E) Amount.--The amount of an implementation 
                grant under this section may not exceed $5,000,000 
                except that the Attorney General may, for good cause, 
                approve a grant in a higher amount.
            ``(5) Priority considerations.--In awarding planning and 
        implementation grants under this section, the Attorney General 
        shall give priority to a State that--
                    ``(A) provides civil liability protection for first 
                responders, health professionals, and family members 
                administering naloxone to counteract opioid overdoses 
                by--
                            ``(i) enacting legislation that provides 
                        such civil liability protection; or
                            ``(ii) providing a certification by the 
                        attorney general of the State that the attorney 
                        general has--
                                    ``(I) reviewed any applicable civil 
                                liability protection law to determine 
                                the applicability of the law with 
                                respect to first responders, health 
                                care professionals, family members, and 
                                other individuals who may administer 
                                naloxone to individuals reasonably 
                                believed to be suffering from opioid 
                                overdose; and
                                    ``(II) concluded that the law 
                                described in subclause (I) provides 
                                adequate civil liability protection 
                                applicable to such persons;
                    ``(B) have in effect legislation or implement a 
                policy under which the State shall not terminate, but 
                may suspend, enrollment under the State plan for 
                medical assistance under title XIX of the Social 
                Security Act (42 U.S.C. 1396 et seq.) for an individual 
                who is incarcerated for a period of fewer than 2 years;
                    ``(C) have a process for enrollment in services and 
                benefits necessary by criminal justice agencies to 
                initiate or continue treatment in the community, under 
                which an individual who is incarcerated may, while 
                incarcerated, enroll in services and benefits that are 
                necessary for the individual to continue treatment upon 
                release from incarceration;
                    ``(D) ensures the capability of data sharing with 
                other States, such as by making data available to a 
                prescription monitoring hub;
                    ``(E) ensures that data recorded in the 
                prescription drug monitoring program database of the 
                State is available within 24 hours, to the extent 
                possible; and
                    ``(F) ensures that the prescription drug monitoring 
                program of the State notifies prescribers and 
                dispensers of schedule II, III, or IV controlled 
                substances when overuse or misuse of such controlled 
                substances by patients is suspected.
    ``(c) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $15,000,000 for each of fiscal 
years 2016 through 2020.''.

                     TITLE VII--OFFSET; GAO REPORT

SEC. 701. OFFSET.

    It is the sense of Congress that the amounts expended to carry out 
this Act and the amendments made by this Act should be offset by a 
corresponding reduction in Federal non-defense discretionary spending.

SEC. 702. GAO REPORT ON IMD EXCLUSION.

    (a) Definition.--In this section, the term ``Medicaid Institutions 
for Mental Disease exclusion'' means the prohibition on Federal 
matching payments under Medicaid for patients who have attained age 22, 
but have not attained age 65, in an institution for mental diseases 
under subparagraph (B) of the matter following subsection (a) of 
section 1905 of the Social Security Act and subsection (i) of such 
section (42 U.S.C. 1396d).
    (b) Report Required.--Not later than 180 days after the date of 
enactment of this Act, the Comptroller General of the United States 
shall submit to Congress a report on the impact that the Medicaid 
Institutions for Mental Disease exclusion has on access to treatment 
for individuals with a substance use disorder.
    (c) Elements.--The report required under subsection (b) shall 
include the following:
            (1) An analysis of whether the following policy changes to 
        the Medicaid Institutions for Mental Disease exclusion would 
        enhance access to treatment for individuals with a substance 
        use disorder:
                    (A) Removing substance use disorder treatment and 
                facilities from the Medicaid Institutions for Mental 
                Disease exclusion.
                    (B) Amending section 1905(i) of the Social Security 
                Act (42 U.S.C. 1396d(i)) to modestly raise the 16-bed 
                limit in the definition of an institution for mental 
                diseases under that section.
                    (C) Repealing the Medicaid Institutions for Mental 
                Disease exclusion.
            (2) An analysis of whether and to what extent the quality 
        of care for substance use disorder treatment is impacted by the 
        Medicaid Institutions for Mental Disease exclusion.
            (3) An analysis of barriers in accessing State-specific 
        information related to the impact of the Medicaid Institutions 
        for Mental Disease exclusion on access to treatment.
            (4) An analysis of the difference in cost between treatment 
        for a substance use disorder in a hospital setting compared to 
        a community-based care setting.
            (5) An analysis of the characteristics of institutions for 
        mental diseases (as defined in section 1905(i) of the Social 
        Security Act (42 U.S.C. 1396d(i))), including the patient 
        capacity of such institutions as well as the type of care 
        setting, among other characteristics.
                                 <all>
```